trimethoprim has been researched along with Acinetobacter Infections in 9 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Acinetobacter Infections: Infections with bacteria of the genus ACINETOBACTER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The old antimicrobial nitroxoline is currently repurposed for oral treatment of uncomplicated urinary tract infections (UTIs)." | 4.12 | In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract. ( Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchs, F | 1 |
| Becerra-Aparicio, F | 1 |
| Xanthopoulou, K | 1 |
| Seifert, H | 1 |
| Higgins, PG | 1 |
| Ambrose, SJ | 1 |
| Hall, RM | 1 |
| Moon, KH | 1 |
| Weber, BS | 1 |
| Feldman, MF | 1 |
| Kwon, HI | 2 |
| Kim, S | 2 |
| Oh, MH | 2 |
| Na, SH | 1 |
| Kim, YJ | 1 |
| Jeon, YH | 1 |
| Lee, JC | 2 |
| Shin, M | 1 |
| Lim, VK | 1 |
| Talib, S | 1 |
| Noble, RC | 1 |
| Cooper, RM | 1 |
| Jarvis, AL | 1 |
| Caples, PL | 1 |
| Todd, EP | 1 |
| Meares, EM | 1 |
| Henderson, ST | 1 |
| Torrez, AJ | 1 |
| Clement, KD | 1 |
9 other studies available for trimethoprim and Acinetobacter Infections
| Article | Year |
|---|---|
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin | 2022 |
A novel trimethoprim resistance gene, dfrA38, found in a sporadic Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Drug Resistance, Multiple, | 2020 |
Subinhibitory Concentrations of Trimethoprim and Sulfamethoxazole Prevent Biofilm Formation by Acinetobacter baumannii through Inhibition of Csu Pilus Expression.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Biofil | 2017 |
Outer membrane protein A contributes to antimicrobial resistance of Acinetobacter baumannii through the OmpA-like domain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Outer Membrane P | 2017 |
Distinct role of outer membrane protein A in the intrinsic resistance of Acinetobacter baumannii and Acinetobacter nosocomialis.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial O | 2019 |
A case of neonatal meningitis caused by Acinetobacter calcoaceticus var anitratus.
Topics: Acinetobacter Infections; Cross Infection; Drug Combinations; Female; Humans; Infant, Newborn; Infan | 1982 |
Trimethoprim-sulfamethoxazole therapy for infective endocarditis.
Topics: Acinetobacter Infections; Aneurysm, Infected; Drug Combinations; Endocarditis, Bacterial; Humans; Kl | 1981 |
Long-term therapy of chronic bacterial prostatitis with trimethoprim-sulfamethoxazole.
Topics: Acinetobacter Infections; Administration, Oral; Adult; Aged; Bacterial Infections; Body Fluids; Drug | 1975 |
Community-acquired nonbacteremic acinetobacter pneumonia.
Topics: Acinetobacter Infections; Blood; Drug Combinations; Humans; Male; Middle Aged; Pleural Effusion; Pne | 1987 |